Gaush Meditech Ltd. logo

Gaush Meditech Ltd. (F7Y)

Market Open
11 Aug, 20:00
XFRA XFRA
0. 52
0
0%
84.85M Market Cap
- P/E Ratio
- Div Yield
1,900 Volume
- Eps
0.52
Previous Close
Add Transaction
Day Range
0.52 0.52
Year Range
0.51 1.12
Want to track F7Y and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

F7Y trading today higher at €0.52, an increase of 0% from yesterday's close, completing a monthly decrease of -1.8868% or -€0.01. Over the past 12 months, F7Y stock lost -39.1813%.
F7Y is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XFRA (EUR).

F7Y Chart

People also search for

722
Antengene Corporation Limited
0.48
-5.7426%
7W3
Acotec Scientific Holdings Limited
0.81
-2.994%
Flerie AB (publ)
1.73
-10.6218%
R9Z
Immuneonco Biopharmaceutical Inc.
0.37
+1.087%
25E
Elan Corporation plc
4.02
+3.0769%

Gaush Meditech Ltd. (F7Y) FAQ

What is the stock price today?

The current price is €0.52.

On which exchange is it traded?

Gaush Meditech Ltd. is listed on XFRA.

What is its stock symbol?

The ticker symbol is F7Y.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 84.85M.

Has Gaush Meditech Ltd. ever had a stock split?

No, there has never been a stock split.

Gaush Meditech Ltd. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Mr. Tieta Gao CEO
XFRA Exchange
KYG3902N1051 ISIN
DE Country
819 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Gaush Meditech Ltd. is a leading enterprise in the field of ophthalmic medical devices, with operations that extend across the People's Republic of China and internationally. Incepted in 1998 and headquartered in Beijing, the company is engaged in the research, development, production, and sales of advanced ophthalmic devices. With a diversified portfolio that addresses a wide range of ophthalmic conditions, Gaush Meditech Ltd. serves a significant role in enhancing eye healthcare. The company asserts its market presence through its Proprietary Products, Distribution, Technical, and Others segments, catering to the comprehensive needs of its clientele ranging from public and private hospitals to various other customers. Besides offering cutting-edge products, the company excels in after-sales support including warranty and maintenance services, alongside equipment leasing and IP licensing amongst its array of services.

Products and Services

  • Proprietary Products:

    This segment involves the development and production of surgical equipment and its supporting software, intra optical lenses, along with diagnosis and treatment equipment for ophthalmic diseases and their related consumables. These products are pivotal in surgeries and treatments for vitreoretinal diseases, cataract, and glaucoma, to name a few, underscoring the company's commitment to innovation and quality in ophthalmic surgery and treatment solutions.

  • Distribution:

    Under this segment, Gaush Meditech Ltd. markets a wide array of diagnostic equipment, surgical and treatment equipment, ocular fundus diagnosis tools, and associated supporting consumables. By partnering with reputable distributors, the company ensures that its top-of-the-line ophthalmic medical devices are accessible to a broader audience, thereby enhancing eye care standards globally.

  • Technical:

    This segment is dedicated to providing warranty services, maintenance services, and after-sales support for all its products. Gaush Meditech recognizes the importance of reliable service post-purchase, offering comprehensive after-sales support to maintain the high performance and longevity of its devices. These services further reinforce the company's reputation for quality and customer satisfaction.

  • Others:

    The Others segment of Gaush Meditech Ltd. encompasses equipment leasing and agent registration services, in addition to the licensing of intellectual properties. This diversification strategy not only broadens the company's revenue base but also facilitates the wider adoption of its technologies and expertise within the ophthalmic medical field.

Contact Information

Address: Building A, Zhonghui Plaza, Beijing, China
Phone: 86 10 5978 6878